An Open-label, Phase 1 Drug Drug Interaction study between Tacrolimus and SCY-078 in Healthy male volunteers

Trial Profile

An Open-label, Phase 1 Drug Drug Interaction study between Tacrolimus and SCY-078 in Healthy male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Apr 2017

At a glance

  • Drugs SCY 078 (Primary) ; Tacrolimus
  • Indications Aspergillosis; Candidiasis; Vulvovaginal candidiasis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 Apr 2017 Results presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases
    • 12 Apr 2017 According to an SCYNEXIS media release, data from this study will be presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
    • 09 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top